Swisse purchased for a healthy price
Biostime International, a Hong Kong-listed producer of infant formula and milk powder, has purchased 83% of Swisse Wellness for $1.39 billion. The transaction is expected to be funded by the issue of 20.5 million shares and a $450 million bridge loan. Financial metrics related to the transaction have not been released, however we expect the company to provide more information to the market shortly. The sale comes after Swisse competitor Blackmores share price hit $136.78, a rise of almost 290% this year due to surging demand from China. HSBC and ANZ Banking Group helped to fund the deal.
Never miss an update
Enjoy this wire? Hit the ‘like’ button to let us know.
Stay up to date with my current content by
following me below and you’ll be notified every time I post a wire
Welcome to Livewire, Australia’s most trusted source of investment insights and analysis.
To continue reading this wire and get unlimited access to Livewire, join for free now and become a more informed and confident investor.
Already have an account? Sign in here
Advertisement
Wilson Asset Management has a track record of making a difference for shareholders and the community for more than 20 years. As the investment manager for eight leading LICs – WAM Capital (ASX: WAM), WAM Leaders (ASX: WLE), WAM Global (ASX: WGB), WAM Microcap (ASX: WMI), WAM Alternative Assets (ASX: WMA), WAM Strategic Value (ASX: WAR), WAM Research (ASX: WAX) and WAM Active (ASX: WAA) – Wilson Asset Management invests over $5.4 billion on behalf of more than 130,000 retail investors.
Wilson Asset Management created and is the lead supporter of the first listed investment companies to deliver both investment and social returns: Future Generation Australia (ASX: FGX) and Future Generation Global (ASX: FGG).

Never miss an update
Get the latest insights from me in your inbox when they’re published.
3 topics
Please sign in to comment on this wire.